---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-001275"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:48:01.033935+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Chromocell raises $750k via convertible note and secures $30M committed equity facility

## Summary
- $750k convertible note issued, 6% interest (12% default), convertible at $1.506/share, floor $0.231, maturity Aug 24, 2025.
- Committed equity facility with Tikkun Capital for up to $30M; shares sold at 90% of VWAP over up to 24 months.
- $750k commitment fee paid to Tikkun; $75k legal fees reimbursed; restrictions on variable rate transactions.
- Stockholder approval required to exceed exchange cap; meeting within 90 days for note; similar cap for equity facility.
- Proceeds to fund clinical work on CC8464 and CT2000 compounds and for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001753926-24-001275
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392624001275/0001753926-24-001275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392624001275/g084348_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-001275
- JSON: https://secwatch.observer/filing/0001753926-24-001275.json
- Plain text: https://secwatch.observer/filing/0001753926-24-001275.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.